drugset / Trial / NCT03933306

Intraoperative Goal-directed Blood Pressure and Dexmedetomidine on Outcomes

NCT03933306 ↗

Phase 4 Completed 496 enrolled Peking University First Hospital
RandomizedFactorialTriple-blindPrevention

Summary

Perioperative organ injuriy remain an important threat to patients undergoing major surgeries. Intraoperative hypotension is associated with an increase in postoperative morbidity and mortality. Whereas individualized intraoperative blood pressure management is likely to decrease the incidence of postoperative organ injury when compared with standard blood pressure management strategy. Dexmedetomidine, a highly selective alpha2 adrenergic agonist, has been shown to provide organ protective effects. This study aims to investigate the impact of intraoperative goal-directed blood pressure management and dexmedetomidine infusion on incidence of postoperative organ injury in high-risk patients undergoing major surgery.

Timeline

Start
2019-05-20
Primary completion
2020-10-29
Completion
2024-05-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Other

Indications

No indication recorded.